Treatment of benign prostatic hyperplasia through transurethral needle ablation (TUNA™): Review of the literature and six years of clinical experience

Urologia Internationalis

Volumn 72, Issue 1, 2004, Pages 32-39

  Braun, M ^a   Mathers, M ^b   Bondarenko, B ^a   Engelmann, U ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b Urology Department   (Germany)

Author keywords

BPH, long term results; Transurethral needle ablation of the prostate

Indexed keywords

CLINICAL TRIAL; FOOD AND DRUG ADMINISTRATION; GERMANY; HUMAN; MEDICARE; PATIENT SELECTION; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; REVIEW; TRANSURETHRAL NEEDLE ABLATION; TREATMENT OUTCOME; UNITED STATES; URODYNAMICS;

CLINICAL TRIALS; HUMANS; MALE; PROSTATIC HYPERPLASIA; TIME FACTORS; TRANSURETHRAL RESECTION OF PROSTATE; URINARY RETENTION; URODYNAMICS;

EID: 1642455837     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075270     Document Type: Review

References (49)

1. Garraway WM, Collins N, Lee RJ: High prevalence of benign prostatic hypertrophy in the community. Lancet 1991;338:469-471.
2. Glynn RJ, Campion EW, Bouchard GR, Silbert JE: The development of benign prostatic hyperplasia among volunteers in the Normative Ageing Study. Am J Epidemiol 1985;121:78-90.
3. Drummond MF, McGuire AJ, Black NA, Petticrew M, McPherson CK: Economic burden of treated BPH in the United Kingdom. Br J Urol 1993;71:290-296.
4. Sökeland J, Schulze H: Entwicklung der Pro-stata-Forschung; in Sökeland J (ed): Benigne Prostata Hyperplasie. Stuttgart, Thieme, 1995, pp 1.15-1.25.
5. Malenka DJ, Roos N, Fischer ES, McLerran D, Whaley FS, Barry MJ, Bruskewitz R, Wennberg JE: Further study of the increased mortality following transurethral prostatectomy; a chart-based analysis. J Urol 1990;144:224-228.
6. van Swol CFP, Verdaasdonk M, Mooibroek J, Boon TA: Optimization of laser prostatectomy. Prog Clin Biol Res 1994;386:511-519.
7. Muschter R, Hessel S, Hofstetter A, Keidisch E, Rothenberger K-H, Scheede P, Frank F: Die interstitielle Laserkoagulation der benignen Prostatahyperplasie. Urologe A 1993;32:273-281.
8. Laduc R, Weil EHJ, Zerbib M, Perrin P, Denis L: Thermotherapy and hyperthermia workshop. Prog Clin Biol Res 1994;386:487-498.
9. Schmidbauer CP: TUNA™ - Behandlung nur mit lokalem Lidocain-Gel in der Praxis: Erste Erfahrungen. Vortrag 7. Urologischer Winter-Workshop (Maria-Alm) 1998;Suppl.
10. Barry SJ, Coffey DS, Walsh PC, Ewing LL: The development of benign prostatic hyperplasia with age. J Urol 1984;132:474-479.
11. Birkhoff JD: Natural history of benign prostatic hypertrophy; in Hinman F Jr (ed): Benign Prostatic Hypertrophy. New York, Heidelberg, Berlin, Springer, 1983, pp 5-9.
12. Lepor H, Shapiro E: This month in investigative urology. Alpha adrenergic innervation of the prostate. Insight into pharmacotherapy. J Urol 1990;143:590-591.
13. Michelle I, Fitton AF, McTavish D: Alfuzosin. Drugs 1993;45:410-429.
14. Rasor JS, Zlotta AR, Edwards SD, Schulmann CS: Transurethral needle ablation (TUNA™): Thermal gradient mapping and comparison of lesion size in a tissue model and in patients with benign prostatic hyperplasia. Eur Urol 1993;24:411-414.
15. Issa MM, Oesterling JE, Roehrborn CG, Bruskewitz R, Naslund MJ, Perez-Marreo R, Shumaker BP: Long-term follow-up of a prospective, randomised clinical United States trial, comparing transurethral needle ablation (TUNA) to transurethral resection of the prostate (TURP) for the treatment of benign prostatic hyperplasia (BPH). Min Inv Ther Allied Technol 1997;6:62.
16. Zlotta AR, Raviv G, Peny M-O, Noel J-Ch, Haot J, Schulman CC: Possible mechanisms of action of transurethral needle ablation of the prostate on benign prostatic hyperplasia symptoms: A neurohistochemical study. J Urol 1997;157:894-899.
17. Oesterling JE, Issa MM, Roehrborn CG, Bruskewitz R, Naslund MJ, Perez-Marrero R, Shumaker BP: Long-term results of a prospective randomised clinical trial comparing TUNA™to TURP for the treatment of symptomatic BPH. J Urol 1997;157(suppl 4):328.
18. Viridi J, Pandit A, Rajagopalan S: Transurethral needle ablation of the prostate (TUNA™) - a prospective study, three years follow up. Eur Urol 1998;33(suppl 1):S9.
19. Bruskewitz R, Issa MM, Roehrborn CG, Naslund MJ, Perez-Marrero R, Shumaker BP, Oesterling JE: A prospective randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia. J Urol 1998;159:1588-1594.
20. Bergamaschi F, Campo B, Ordesi G, Trelli T: Prospective not randomised study of TUNA™ vs. TURP for patients with BPH demonstrating moderately high detrusor pressures and elevated symptom score. Eur Urol 1996; 30(suppl 2):262.
21. Hill B, Belville W, Bruskewitz R, Issa M, Perez-Marrero R, Roehrborn C, Terris M, Naslund M: Five year results of a prospective randomized trial comparing transurethral needle ablation (TUNA) to TUR-P for treatment of symptomatic BPH. J Urol 2002;167(suppl 4):294.
22. Issa MM: Transurethral needle ablation of the prostate: Report of initial United States clinical trial. J Urol 1996;156:413-419.
23. Campo B, Bergamaschi F, Corrada P, Ordesi G: Transurethral needle ablation (TUNA™) of the prostate: A clinical and urodynamic evaluation. Urol 1997;49:847-850.
24. Steele GS, Sleep DJ: Transurethral needle ablation of the prostate: A urodynamic based study with 2-year follow-up. J Urol 1997;158:1834-1838.
25. Rosario DJ, Woo H, Potts KL, Cutinha PE, Hastie KJ, Chapple CR: Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction. Br J Urol 1997;80:579-586.
26. Braun M, Zumbé J, Korte D, Solleder G, Heidenreich A, Engelmann U: Transurethral needle ablation of the prostate: A minimally invasive therapeutic concept in the treatment of benign prostate hyperplasia. Urol Int 1998;61:104-110.
27. Harewood LM, Cleeve LK, O'Connell HE, Pope AJ, Vaughan MG, Agarwal D: Transurethral needle ablation of the prostate (TUNA™): Clinical results and ultrasound, endoscopic, and histologic findings in pilot study of patients in urinary retention. J Endurol 1995;9:407-412.
28. Zlotta AR, Peny M-O, Matos C, Schulman CC: Transurethral needle ablation of the prostate: Clinical experiences in patients in urinary retention. Br J Urol 1996;77:391-397.
29. Braun M, Neubauer S, Derakhshani P, Heiden-reich A, Engelmann U: Die transurethrale Nadelablation der Prostata bei Hochrisikopatienten. Vortrag 8. Urologischer Winter-Workshop (Maria-Alm). 1999;suppl.
30. Schulman CC, Zlotta A: Transurethral needle ablation of the prostate (TUNA ™): Pathological, radiological and clinical study of a new office procedure for treatment of benign prostatic hyperplasia using low-level radiofrequency energy. Semin Urol 1994;12:205-210.
31. Heaton JPW: Radiofrequency thermal ablation of the prostate: The TUNA™ technique. Tech Urol 1994;1:3-10.
32. Eardley I, Fitzpatrick J, Frick J, Goldwasser B, Wicklund P: TUNA™-Therapy for symptomatic prostatic hyperplasia. A collaborative European trial. J Urol 1995;153(suppl):371.
33. Schulman CC, Zlotta A: Transurethral needle ablation of the prostate for treatment of benign prostatic hyperplasia: Early experience. Urol 1995;45:28-33.
34. Schulman CC, Zlotta A: Transurethral needle ablation (TUNA™) of the prostate: Clinical experience with two years follow-up patients with benign prostatic hyperplasia. Eur Urol 1996;30(suppl 2):263.
35. Giannakopoulos X, Grammeniatis E, Garrzois A, Pappas G: Transurethral needle ablation (TUNA™) of the prostate: Preliminary results using the new generation TUNA™III catheter on patients with symptomatic BPH controlled by a series of 50 patients using the TUNA™ device. Eur Urol 1996;30(suppl 2):263.
36. Ramon J, Lynch TH, Eardley I, Ekman P, Frick J, Jungwirth A, Pillai M, Wiklund P, Goldwasser B, Fitzpatrick JM: Transurethral needle ablation of the prostate for the treatment of benign prostatic hyperplasia: A collaborative multicentre study. Br J Urol 1997;80:128-135.
37. Pandit A, Sriram R, Virdi J: Transurethral needle ablation (TUNA™) of the prostate - a prospective study. Presentation at the 3rd International Consultation on BPH (Paris), 1997.
38. Rosario DJ, Woo H, Potts KJ, Cutinha PE, Hastie KJ, Chapple CR: Safety and efficacy of transurethral needle ablation of the prostate for symptomatic outlet obstruction. Br J Urol 1997;80:579-586.
39. Roehrborn CG, Issa MM, Bruskewitz RC, Naslund MJ, Oesterling JE, Perez-Marrero R, Shumaker BP, Narayan P: Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter US study. Urol 1998;51:415-421.
40. Narayan P, Starling J: Minimally invasive therapies for the treatment of symptomatic benign prostatic hyperplasia: The University of Florida experience. J Clin Laser Med Surg 1998;16:29-32.
41. Bergamaschi F, Manzo M, Autieri G, Corrada P, Campo B: Five years experience using transurethral needle ablation (TUNA) in 204 BPH patients. J Urol 2001;163(suppl 4):333-334.
42. Zlotta AR, Schulman C, Giannakopoulos X, Maehlum H: Long-term evaluation of transurethral needle ablation of the prostate (TUNA) for the treatment of benign prostatic hyperplasia (BPH): Clinical outcome after 5 years - a 3 centers experience. J Urol 2002;167 (suppl 4):291.
43. Chandrasekar P, Virdi JS: Transurethral needle ablation of the prostate (TUNA®) - A prospective study, six-year follow-up
44. Arai Y, Fukuzawa S, Terai A, Yoshida O: Transurethral microwave thermotherapy for benign prostatic hyperplasia: Relation between clinical response and prostate histology. Prostate 1996;28:84-88.
45. Tubaro A, Carter S, de la Rosette J, Höfner K, Trucchi A, Ogden C, Miano L, Valenti M, Jonus U, Debruyne F: The prediction of clinical outcome from transurethral microwave thermotherapy by pressure flow analysis: An European multicenter study. J Urol 1995;153:1526-1530.
46. Rotman M, Salant R, Nagler H: A comperative analysis of transurethral needle ablation and interstitial laser thermal therapy of the prostate. J Urol 2002;167(suppl 4):295.
47. Madersbacher S, Djavan B, Marberger M: Minimally invasive treatment for benign prostatic hyperplasia. Curr Opin Urol 1998;8:17-26.
48. Chiang PH, Tsai EM, Chiang CP: Pilot study of transurethral needle ablation (TUNA™) in treatment of nonbacterial prostatitis. J Endourol 1997;11:367-370.
49. Giannakopoulos X, Balatogiannis D, Tsava-las S, Tasos A, Filiadis A, Sofikitis N: Chronic nonbacterial prostatitis and T.U.N.A.: A promising new therapy. J Urol 2001;165 (suppl 5):294-295.